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Nanomaterials possess unique features which make them particularly attractive for
biosensing applications. In particular, carbon nanotubes (CNTs) can serve as scaffolds
for immobilization of biomolecules at their surface, and combine several exceptional
physical, chemical, electrical, and optical characteristics properties whichmake them one
of the best suited materials for the transduction of signals associated with the recognition
of analytes, metabolites, or disease biomarkers. Here we provide a comprehensive review
on these carbon nanostructures, in which we describe their structural and physical
properties, functionalization and cellular uptake, biocompatibility, and toxicity issues.
We further review historical developments in the field of biosensors, and describe the
different types of biosensors which have been developed over time, with specific focus
on CNT-conjugates engineered for biosensing applications, and in particular detection of
cancer biomarkers.
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HISTORY AND INTRODUCTION TO CARBON NANOTUBES
Brought to our planet from the red giant stars, carbon is a singular element in the periodic table:
it can bind itself or other atoms without a great expense of energy. Fundamental for the living
world, carbon has long been known to exist in three allotropic forms: graphite, diamond, and
amorphous carbon. After the Second World War, in the middle of the last century, tremendous
progress in the science of carbon led to unexpected and fascinating findings. For example
lonsdaleite, also called hexagonal diamond, was first identified in 1967 from the Canyon Diablo
meteorite, where it occurred as microscopic crystals associated with diamond. Later, the discovery
of buckminsterfullerenes (C60) (Kroto et al., 1985) marked the beginning of a new era in carbon
science. The impact was so huge that its discoverers, Robert Curl Jr., Harold Kroto and Richard
Smalley were awarded the Nobel Prize in Chemistry in 1996.
Here we will focus on carbon nanotubes (CNTs), also called buckytubes and first evidenced in
1991 by the Japanese electron microscopist Sumio Iijima. Since his first report on multi-walled
carbon nanotubes (MWNTs) (Iijima, 1991), followed by their single-walled counterparts (SWNTs)
(Iijima and Ichihashi, 1993; Journet et al., 1997), CNTs have emerged as one of the most intensively
investigated nanostructured materials (Balasubramanian and Burghard, 2005), with thousands of
papers published every year, offering promises for new applications which have attracted both
Abbreviations:AFM, atomic force microscopy; AFP, autofluorescent Protein; BPE, bipolar electrode; CNT, carbon nanotube;
DWNT, double-walled carbon nanotube; FET, field-effect transistors; FRET, fluorescence resonance energy transfer; GFP,
green fluorescent protein; GOx, glucose oxidase; HER2, human epidermal growth factor receptor 2; MRI, magnetic resonance
imaging; MWNT, multi-walled carbon nanotube; NIR, Near Infra-Red; OPN, osteopontin; PAABD, phosphor amino acid
binding domain; PEI, polyethylenimine; PSA, prostate specific antigen; RBM, Radial Breathing Mode; ROS, reactive oxygen
species; SSA, specific surface area; SWNT, single-walled carbon nanotube; TEM, transmission electron microscopy; VOC,
volatile organic compounds.
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academic and industrial interest. CNTs are hollow carbon
structures, with one or more walls, a nanometer scale diameter
and a comparatively more important length. They exhibit a well-
ordered arrangement of carbon atoms linked via sp2 bonds,
which makes them the stiffest and strongest fibers known. Their
advantage compared to other nanomaterials lies in a unique
combination of electrical, magnetic, optical, mechanical, and
chemical properties, which offer great promises for a wide range
of applications, including biosensing (Le Goff et al., 2011; Biju,
2014).
Besides, CNTs can serve as platforms to conjugate other
compounds at their surface (exohedral functionalization) (Arkan
et al., 2015; Shobha and Muniraj, 2015). Moreover, CNTs shells
can be opened and filled (endohedral functionalization) without
losing their stability (Sloan et al., 1998).
Importantly, functionalized CNTs can effectively cross
biological barriers such as the cell membrane and penetrate
individual cells (Pantarotto et al., 2004b). This feature and the
mechanism of internalization and release of CNTs from the cells
are of major interest for biological and in particular intracellular
biosensing applications.
Generally, the successful application of CNTs for biomedical
tests faces a variety of challenges prerequisites. These include:
(a) synthesis of CNTs with tailored functionalities and uniform
morphology; (b) modification of CNTs to make them compatible
with biological systems; (c) detailed study of their interaction
with biological environments (toxicity, interaction with
single cells); (d) in vivo testing for specific therapeutic and
diagnostic purposes such as imaging (contrast agents, markers),
sensing (nanoparticle-based diagnostics) and cancer treatment
(hyperthermia, drug delivery).
Structure and Properties
Depending on their number of walls, CNTs are designated single-
walled (SWNTs) or multi-walled (MWNTs). Cylinder-shaped
SWNTs with diameters as small as a nanometer (or less) can
be grown up to 20 cm in length (Zhu et al., 2002). The side-
walls of these tubes are made up of a hexagonal lattice of carbon
atoms, similar to the atomic planes of graphene and are usually
capped at both ends by one half of a fullerene-like molecule.
SWNTs possess the simplest morphology and can be visualized
as a single rolled up graphene sheet. Based on the orientation of
the tube axis with respect to the hexagonal lattice, the structure
of a nanotube can be simply defined through its chiral vector,
which is defined by the chiral indices (n, m). SWNTs are classified
by the geometric arrangement of the carbon atoms at the seam
of the cylinders. While most SWNTs are chiral (m 6= n),
some of them present armchair (m = n) or zigzag (m = 0)
configurations (Figure 1A).
In the most general case, a CNT is composed of a concentric
arrangement of several cylinders (Figure 1C). Such MWNTs can
reach diameters of up to 100 nm and the distance between two
walls is very close to the distance between two graphene layers
in graphite (∼3.5 Å) (Balasubramanian and Burghard, 2005).
Double-walled carbon nanotubes (DWNTs) are a special case of
MWNTs, composed of just two concentric cylinders (Figure 1B).
DWNTs bridge the gap between SWNTs and MWNTs, thereby
cumulating properties of both kinds of CNTs. More specifically,
DWNTs resemble SWNTs with respect to their small diameter,
length and ability to form bundles, but their mechanical stability
is much greater than that of the SWNTs, especially when
covalently functionalized (Yang et al., 2010). Moreover, the outer
wall of DWNTs can be functionalized without affecting the
mechanical and electrochemical properties of the inner tube, just
like MWNTs (Pumera, 2007).
Besides, CNTs have a large specific surface area (SSA), which
enables immobilization of a large number of functional units
at the carbon nanotube surface, such as receptor moieties for
biosensing applications. In practice, the bundling effect, as well
as the increase in the number of walls, decreases the SSA
of CNTs (Peigney et al., 2001). It is worth noting that the
properties of CNTs may differ significantly between MWNTs
and SWNTs. SWNTs are unique nanostructures with unusual
electronic properties, because of the one-dimensional quantum
effect. Depending on their diameter and chirality, CNTs may be
either semi-conducting or semi-metallic (Hamada et al., 1992;
Saito and Yoshikawa, 1993). For example, the armchair structure
behaves as a metallic material, whereas the zigzag structure has
semi-conductor or quasi-metallic properties. In the latter case,
the width of the band gap of the semi-conductor decreases with
the increase of CNT diameter (Mintmire and White, 1995). Two
properties are responsible for the high electrical conductivity of
metallic CNTs: they have very few defects to scatter electrons
and they present a good stability at high temperatures (up to
300◦C in air and 1500◦C in vacuum). Hence, a good ballistic
conduction is also detected (Frank et al., 1998). Moreover, their
mechanical properties are excellent, combining high strength
with high stiffness. The tensile strength of SWNTs is about 20
times that of steel (Yu et al., 2000) and the Young’s modulus of
CNTs is much greater than that of steel fibers. CNTs may also
present a positive or negative magnetoresistance, as a function of
the temperature and the applied magnetic field. For example, in
a weak magnetic field, nanotubes exhibit large diamagnetic and
paramagnetic responses, depending on the field direction, Fermi
energy, helicity, and size of the nanotubes (Lu, 1995).
Owing to their quasi 1-D nature, SWNTs exhibit strong
resonance Raman scattering, high optical absorption and
photoluminescence in the Near Infra-Red (NIR) range,
properties that present a high interest for imaging in biological
systems in vitro and in vivo (Zhou et al., 2009). The most
important feature in the Raman spectrum of CNTs is the Radial
Breathing Mode (RBM), which is often located between 100
and 250 cm−1, providing information about the CNT diameters
(Michel et al., 2009). The increase of the RBM frequency
indicates that the CNTs agglomerate in bundles. Then, two bands
are located between 1300 and 1700 cm−1: the D band, at about
1320 cm−1 is due to the phonons induced by the crystalline
disorder and it gives information about the CNT structural
defects (sp3 carbon); the G band, at about 1580 cm−1, is
characteristic of the carbon sp2 hybridization. The ratio of these
two bands intensities (ID/IG) gives general information about
the structural quality of the CNT. The ID/IG ratio increases with
the level of defects on the CNT surface. Another band appears at
2600 cm−1, the G’2D band, which confirms the presence of CNTs
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FIGURE 1 | Structure and models of carbon nanotubes in function of their number of walls. (A) Single-walled carbon nanotubes (SWNTs) structures in
function of their chirality (zigzag, armchair, and chiral). (B) Model of double-walled carbon nanotubes (DWNTs). (C) Structure of multi-walled carbon nanotubes
(MWNTs) made up of several concentric shells.
in the biological samples. This band corresponds to a second
order of the CNT vibration.
Photoluminescence from SWNTs, as well as optical absorption
and Raman scattering, are linearly polarized along the tube
axis. This allows monitoring the SWNT orientation without
direct microscopic observation. Indeed, semiconducting single-
walled CNTs emit near-infrared light upon photoexcitation,
described interchangeably as fluorescence or photoluminescence.
However, no excitonic luminescence can be produced in metallic
tubes. Their electrons can be excited, thus resulting in optical
absorption, but the holes are immediately filled by other electrons
of the many available in the metal. Therefore, no excitons are
produced. Hence, photoluminescence is used for characterization
purposes to measure the quantities of semiconducting nanotube
species in a sample.
Another attractive property of these carbon nanostructures is
their exceptional photothermal response. Photothermal therapy
is used to reduce the size of tumors or even to eliminate them.
SWNTs have been shown to serve as photothermal therapeutic
agents to destroy cancer cells, using NIR laser irradiation to
generate heat, following SWNTs internalization (Kam et al., 2005;
Chakravarty et al., 2008).
CNTs may further be filled with different ferromagnets,
therapeutics, sensors, or magnetic resonance contrast agents
for applications such as sensoring (Klingeler et al., 2008),
hyperthermia cancer treatment (Singh and Torti, 2013), drug
delivery (Hampel et al., 2008), biosensing (Oh et al., 2013), or
magnetic resonance imaging (MRI) (Sitharaman et al., 2005).
Last but not least, the high optical absorption of SWNTs
can also be used in photoacoustic imaging. This method
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has higher spatial resolution than traditional ultrasound and
deeper tissue penetration than fluorescence imaging (Xu and
Wang, 2006). In 2010, a novel photoacoustic contrast agent
based on Indocyanine Green dye-enhanced single-walled carbon
nanotubes (SWNT-ICG) was developed which yielded a 300
fold greater photoacoustic contrast in living tissues than
previously reported SWNTs with subnanomolar sensitivity
(Zerda et al., 2010). Hence, thanks to the combination of
their unprecedented properties, CNTs are extremely well suited
for a wide variety of challenging biomedical applications
(Figure 2).
Functionalization
Exohedral Functionalization
One of the major issues with CNTs for applications in the
biomedical field is the inherent difficulty to handle them. Indeed
CNTs tend to aggregate into bundles through strong attractive
interactions, which are very difficult to disrupt. As grown, pristine
buckytubes have highly hydrophobic surfaces and are not soluble
in water or any common solvents. Introduction of functional
groups onto the surface of CNTs therefore helps to solubilize
them and facilitates their study (O’connell et al., 2001; Tasis et al.,
2003).
Surface functionalization of CNTs may be non-covalent or
covalent.
Non-covalent Functionalization of CNTs
Non-covalent functionalization has many advantages, mainly
the preservation of the structural and electrical properties of
CNTs. Furthermore, these procedures are usually quite simple
and fast, involving steps such as ultrasonication, centrifugation,
and filtration. The structures that the surfactant molecules
(commonly used for non-covalent functionalization) adopt
when they are attached to the carbon nanotube’s wall are
diverse (Figure 3). In the case of charged surfactants, the
dispersion of nanotubes is stabilized by electrostatic repulsion
between micelles (Figure 3A); in the case of charge-neutral
surfactants, the hydrophilic moieties of surfactants create a shell-
like structure, which appears assembled around the nanotube
(Figure 3B).
Although surfactants are efficient in the solubilization of
CNTs, they are known to permeabilize the plasma membrane.
Being for the greater part cytotoxic, surfactants may therefore
limit biological application of such functionalized CNTs.
Recently, Holzinger et al. developed an original method for
the synthesis of multivalent biosensors based on non-covalent
triple functionalization of SWNTs (Holzinger et al., 2010). In
this study, three different pyrene derivatives were simultaneously
immobilized on the nanotube’s surface by pi-stacking in a
one-step reaction by simple dip coating of nanotubes coating
electrodes.
Furthermore, single-stranded DNA molecules have been
widely used to solubilize SWNTs by virtue of the pi–pi stacking
between hydrophobic DNA base units and the nanotube’s surface
(Tu and Zheng, 2008). However, the main disadvantage of non-
covalent functionalization when it is used for gene delivery is that
DNA binding to the nanotubes may be unstable (Kostarelos et al.,
2007).
FIGURE 2 | Applications of carbon nanotubes.
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FIGURE 3 | Exohedral and endohedral functionalization of CNTs. (A) Non-covalent surface functionalization of a buckytubes with a micellar surfactant or
(B) with a shell-like surfactant wrapping around the nanotubes. In both cases, hydrophobic groups are evidenced by blue lines and hydrophilic ones by yellow stars.
(C) Model of nanotubes filled with “peapods” (C60). (D) DWNTs filled on all the length with molten FeI2 (FeI2@DWNTs).
In fact, an ideal non-covalent functionalization coating on
CNTs for biological applications should be (1) biocompatible
and non-toxic, (2) stable enough to avoid detachment from
the nanotube’s surface in biological solutions, especially in
serum having high salt and protein contents, and having very
low critical micellar concentration values, so that it remains
stable after removal of excess coating molecules from the CNT
suspension, (3) bear functional groups which are available for
bioconjugation with antibodies or other molecules so as to
enable subsequent preparation of CNT conjugates for different
purposes.
Non-covalent functionalization of SWNTs by PEGylated
phospholipids meets these requirements, including high water
solubility of nanotubes and versatile functionalities (Liu et al.,
2007, 2008). MWNTs have been grafted with polyethylenimine
(PEI), a positively charged polymer, known for its excellent
binding properties to DNA (Liu et al., 2005). This approach
may be exploited to prepare highly sensitive and low toxic CNT-
based DNA sensors (or probes) and novel safe and efficient gene
delivery systems.
RNA-wrapping is another attractive method to solubilize
CNTs and yielding high solubilization and no cytotoxicity.
However, RNA-wrapping confers negative charges to the CNTs
that make them unsuitable for DNA binding. To overcome this
problem, Sanz et al. used a cationic polymer as a bridge between
the negatively charged RNA wrapped around the CNT and the
negatively charged plasmid DNA (Sanz et al., 2011a). Hence,
the best conditions for plasmid DNA binding were obtained
with PEI, but, given its cytotoxicity, the best combination for
solubilization and DNA binding was poly(Lys:Phe, 1:1), which is
less toxic.
Covalent Functionalization of CNTs
Various covalent reactions have been developed to functionalize
CNTs, oxidation being one of the most common. CNT oxidation
is often carried out with oxidizing agents such as nitric acid
(Rosca et al., 2005). During this process, carboxylic groups are
formed at the ends of the tubes, as well as at defective sites
on the sidewalls (Figure 3B). Despite the robustness of covalent
functionalization, the intrinsic physical properties of CNTs, such
as photoluminescence and Raman scattering are often modified,
even destroyed after chemical reactions, due to the disrupted
nanotube structure. The intensities of Raman scattering and
photoluminescence of SWNTs are drastically decreased after
covalent modification, reducing the potential of these materials
for optical applications (Liu et al., 2009). However, a mild and
green method of CNT oxidation using K2FeO4 was recently
developed, producing hydrophilic CNTs with abundant surface
-COOH groups (Zhang and Xu, 2015). Fe(IV) oxidation of CNTs
was indeed detected at the initial defects of the carbon shell,
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specifically on sp3-C, without affecting the C=C bonds in the
hexagonal rings.
Zeng et al. also observed sp3-carbon atoms on SWNTs after
oxidation and further covalent conjugation with aminoacids
(Zeng et al., 2008). However, although oxidized CNTs are rather
“soluble” in water, they aggregate in the presence of salts, due
to charge screening effects and thus cannot be directly used
for biological applications, because of the high salt content of
most biological solutions. Further modification can be achieved
by attaching hydrophilic polymers, such as polyethylene glycol
to oxidized CNTs, yielding CNT-polymer conjugates which are
stable in biological environments (Liu et al., 2007).
Another widely used type of covalent reaction to functionalize
CNTs involves cycloaddition, which occurs on the aromatic
sidewalls, instead of the nanotube’s ends and defects as in the case
of oxidation. The 1,3-dipolar cycloaddition reactions on CNTs
developed by Prato et al. is now commonly used (Pantarotto et al.,
2004b).
Due to the high specific area of the CNTs, multiple copies of
different molecules can be introduced onto the nanotube surface,
which opens the door to perform multiple functions. For this
purpose, different strategies have been reported for the double
and triple covalent functionalization of buckytubes (Lamanna
et al., 2011; Ménard-Moyon et al., 2011). The double covalent
functionalization of CNTs based on the subsequent derivatization
of oxidized CNTs by 1,3-dipolar cycloaddition and by amidation
was first published in 2005 (Wu et al., 2005). CNTs were
functionalized with molecules bearing primary amines blocked
by orthogonal protecting groups. Hence, the use of specific
conditions to selectively deprotect some of the amine functions
allowed control of amine derivatization with an imaging probe
and a therapeutic agent. Other double functionalization methods
were based on double 1,3-cycloaddition (Pastorin et al., 2006),
double amidation (Bhirde et al., 2009), a combination of 1,3-
dipolar cycloaddition of azomethine ylides and arylation using
diazonium salts (Brunetti et al., 2007) or a combination of
amidation or arylation reactions (Stephenson et al., 2007).
Importantly, it was shown that the degree of functionalization
alters tissular distribution and excretion profiles (Al-Jamal
et al., 2012). Increased CNT functionalization indeed enhances
renal clearance, while lower functionalization promotes
reticuloendothelial system accumulation. Therefore, by tuning
the degree of surface chemical functionalization of nanotubes,
greater control over their organ distribution and clearance
profiles in vivo can be achieved, which is of course essential for
CNT-based diagnostics and therapeutics.
To summarize, it was proven through various studies that
surface functionalized CNTs can behave in a biologically different
and safer manner, compared to their pristine counterparts
(Lamprecht et al., 2009; Heister et al., 2010; Marchesan et al.,
2015), which may easily agglomerate into bundles and contain
residual impurities, such as metal catalyst nanoparticles or
amorphous carbon.
Endohedral Functionalization
The filling of CNTs represents a striking example of matter
manipulation at the nanometric scale. Indeed, the cylindrical
inner cavity of CNTs can be filled with foreign materials for
various applications. The study of X@CNTs (Monthioux et al.,
2006) (carbon nanotubes filled with different atoms, molecules
or compounds “X”) started with the incidental discovery that
fullerenes could enter SWNTs, thereby forming the so-called
“peapods” (Smith et al., 1998; Figure 3C).
The filling of nanotubes while they grow (in situ filling) can be
achieved through electric arc process (Ajayan and Lijima, 1993)
or CCVD procedure (Hampel et al., 2006). However, in most
cases, the filling step is separated from synthesis (ex situ filling)
and two methods can be distinguished: the filling in solution
(through wet chemistry route) and the filling with a melted phase
(by a physical route).
Filling of CNTs from Solutions
This method consists in bringing into contact a concentrated
solution of the desired material to be filled (generally a
“precursor”) with open nanotubes. The first study on the large
size MWNTs filled with metal precursors was described in 1994
(Tsang et al., 1994). Molecular dynamic simulation has shown
that nucleic acids could also be inserted into the hollow cavity
of CNTs in an aqueous environment, providing that the CNT
diameter exceeds a critical value of 1.08 nm (Gao et al., 2003).
In addition, CNTs can be filled with anticancer (Hampel et al.,
2008; Tripisciano et al., 2009) or anti-malarial drugs (Sanz et al.,
2011b).
In parallel, efforts have been made to fill SWNTs or DWNTs
with smaller diameters. SWNTs were filled with ruthenium
chloride (Sloan et al., 1998). Recently, Bortolamiol et al. described
DWNTs filling with uranyl nitrate (Bortolamiol et al., 2014).
One of the biggest advantages of this method is that
sensitive biological compounds with low melting point or high
decomposition rate can be easily dissolved and introduced
into the CNTs, which would otherwise be impossible through
a physical route. However, this strategy requires CNTs to
be opened, usually in aggressive conditions, which may lead
to damaging of the outer wall or surface functionalization.
Moreover, filling yield tends to be rather low (scarcely above
20%) and dramatically reduced with a decrease in CNT diameter,
which makes the task rather difficult in the case of SWNTs and
DWNTs.
Filling of CNTs fromMelted Phases
The physical method involving a melted phase is more restrictive
than the wet chemistry route: first, because some materials may
start to decompose before they melt and second, because the
melting point has to be compatible with the process.
The mechanism of the nanotube’s opening during the process
of filling with melted compounds is still not clearly established,
but is certainly related to the chemical aggressiveness of the
molten materials toward the structural defects of CNTs, mainly
at the tips.
Filling yields are greater than for filling in solution, although
the exact percentage of filled tubes in the entire sample is
not always easily to determine, and the yield is often deduced
from transmission electron microscopy (TEM) observations.
In 2009, the first methodology for the quantitative assessment
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of the amount of material encapsulated in filled CNTs was
reported, based on thermogravimetric analyses in air of the filled
buckytubes (Ballesteros et al., 2009).
CNTs can be filled with melted metals (Saito and Yoshikawa,
1993), salts (Kitaura et al., 2008), semiconductors (Chimowa
et al., 2011), metallic precursors for hyperthermia cancer
treatment (Tîlmaciu et al., 2009), or with contrast agents for MRI
(Law et al., 2014). Hence, buckytubes constitute smart carrier
systems which may be filled with tailored materials to address
specific demands (Figure 3D).
To conclude, the melted phase method is the first preferred
method in terms of filling yields with various compounds,
although its main limitation is the thermal stability of the filling
material.
Cellular Internalization and Biodistribution
Biological barriers exist to protect the living cells from invasion
of foreign nanomaterials. The biodistribution of any exogenous
biomolecule is therefore primarily ruled by its ability to
cross the cell membrane and gain access into the subcellular
media. Pantarotto and colleagues published the first evidence
that buckytubes translocate across cell membranes, describing
this process as endocytosis-independent (Pantarotto et al.,
2004b). Thus, it was proposed that water-soluble amino-
functionalized SWNTs behave like cell-penetrating peptides and
related synthetic oligomers. It was further shown that uptake
of DNA by CNTs enabled gene expression (Pantarotto et al.,
2004a). It was hypothesized that cationic amino-functional
groups bind the nanotubes to the cell membrane, facilitating a
spontaneous insertion mechanism through the biomembrane.
This “nanoneedle” mechanism (Figure 4A) was thus proposed
for the interaction of SWNTs with human cervical cancer
cells (HeLa), when the nanotubes were observed crossing
the plasma membrane barrier by TEM. Additionally, various
types of functionalized CNTs were found to be taken up
by a wide range of cells, some of which are deficient in
phagocytotic function (fibroblasts) or lack the capacity to
undergo endocytosis (fungi, yeast and bacteria) (Kostarelos et al.,
2007). Hence, the term “nanosyringe” was adopted by Lopez
et al. to describe a model whereby nanotubes interact with lipid
bilayers by direct diffusion through the membrane (Lopez et al.,
2004).
In contrast, Kam and collaborators reported the endocytotic
uptake of SWNTs and SWNTs-streptavidin by mammalian cells
(Kam et al., 2004; Figure 4B). Further studies showed that
SWNTs functionalized with proteins and nucleic acids penetrated
FIGURE 4 | Cellular internalization of carbon nanotubes via “nanoneedle” mechanism vs. endocytotic pathway, following in vivo injection. (A)
Functionalized CNT rapidly penetrates the cell membrane directly to the nucleus, where it releases the cargo (red circles). (B) Functionalized CNT is internalized in the
cell by endocytosis and delivered to the endosome, which matures to a lysosome. The accumulation into the lysosome causes swelling and rupture of the vesicle
followed by the release of the functionalized CNT into the cytoplasm. The cargo is then able to diffuse through the cytoplasm.
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cell membranes by clathrin-mediated endocytosis (Kam et al.,
2006).
Besides, it was shown that DNA-wrapped SWNT uptake
is length-selective (Becker et al., 2007). Additionally, the
functionalized-CNTs diameter appears to be an important factor
since large-diameter CNTs were found to be more cytotoxic than
small-diameter CNTs. Nevertheless,MWNTs allow for prolonged
release of the encapsulated drug, thereby increasing its anticancer
efficacy (Muzi et al., 2015).
CNT uptake was further observed by atomic force microscopy
(AFM) to visualize non-covalently functionalized SWNTs
and DWNTs immobilized on plasma membranes or nuclear
envelopes (Lamprecht et al., 2009). Recently, the same team
demonstrated folic acid mediated CNT binding to human
carcinoma cells and their transport into the cytosol by AFM and
molecular recognition force spectroscopy (MRFS) (Lamprecht
et al., 2014).
Jin and co-workers reported the first example of exocytosis
and showed that the rate of exocytosis closely matches that
of endocytosis by single particle tracking (Jin et al., 2008).
Neves et al. further described release of RNA-wrapped oxidized
DWNTs from PC3 cells (Neves et al., 2010). CNT uptake and
release occurred within 24 h, with no significant changes in
cell structure or loss of viability. Cells gradually released CNTs,
with a marked four-fold decrease in cellular accumulation after
12 h incubation, the presence of CNTs being negligible after
24 h. Moreover, the potential of DNA-SWNTs as long-term
cellular biomarkers and sensors was also assessed (Heller et al.,
2005).
Multiple studies have been performed to investigate the
internalization of soluble CNTs in neurons (Cellot et al., 2010;
Al-Jamal et al., 2011) and the fate of functionalized CNTs into the
brain was evaluated (Bardi et al., 2013). Histological examination
of sequential coronal sections after injection of functionalized
MWNT-NH+3 with lengths between 0.5 and 1µm in the
murine cortex revealed that pristine MWNT-NH+3 were more
widely dispersed in brain parenchyma compared to oxidized
MWNT-NH+3 . In order to better visualize the localization of
functionalized MWNT-NH+3 , TEM analysis was also performed
and showed that both CNTs were predominantly uptaken by
microglia neural tissue cells. Once internalized, MWNT-NH+3
were visualized either as free individualized nanotubes in the
cytoplasm or within vesicles.
Interestingly, studies of functionalizedMWNT trafficking and
subcellular localization in Catharanthus roseus plant protoplasts
revealed an endosome-escape uptake mechanism (Serag et al.,
2011). Moreover, at short diameters (<100 nm), the CNTs were
found to target specific cellular structures including the nucleus,
plastids and vacuoles.
In conclusion, although much progress has been made
toward our understanding of how nanotubes interact with
cell membranes and penetrate into cells, the mechanisms of
uptake, intracellular localization and biodistribution appear to
vary with functionalization, length, diameter, number of walls,
and concentration of CNTs. Irrespective, CNTs have emerged
as promising nanocarriers for drug delivery, diagnostics, and
molecular imaging.
Toxicity and Biocompatibility
Safety is the first requirement of any material used for
biomedical purposes. Together with the growing number of CNT
applications in nanomedicine (Vardharajula et al., 2012; Mundra
et al., 2014), questions are raised about the potential toxicity of
these nanomaterials.
Toxicity can be assessed through exposure of cultured cells
to suspensions of CNTs, prepared with or without addition
of surfactant, and dispersion by sonication. Indeed surfactants,
present in excess in CNT suspensions, are known to be highly
toxic for cells and may therefore contribute to the observed
toxicity of CNT samples whenever present (Dong et al., 2008).
The metal catalyst content in CNTs can generate free radicals
that can cause oxidative damage to cells and membranes, if they
are not removed during purification (Plata et al., 2008). This is
especially important since the annual production of buckytubes
is now reaching hundreds of tons per year.
To address the possible side effects of CNTs on human
health and environment, the toxicology of CNTs has been
investigated on animal models. In a pilot study, Poland et al.
noticed the structural similarity of CNTs with asbestos fibers.
Following intraperitoneal injection, the mesothelial lining of
the mouse body cavity was exposed to large MWNTs (length
10–50µm, diameter 80–160 nm), which were simply sonicated
in 0.5% bovine serum albumin solution, without any surface
functionalization (Poland et al., 2008). Hence, this study cannot
be related to functionalized CNTs with biocompatible coatings
recommended for biomedical applications. Moreover, it is worth
noting that functionalized SWNTs used routinely in biomedical
research have a length of 50–300 nm and a diameter of 1–2 nm,
which is much smaller than the MWNTs used by Poland et al.
(Yang et al., 2008). Other studies on unpurified, pristine CNTs
have reported that buckytubes can induce granuloma, fibrosis, or
inflammation following lung administration (Muller et al., 2005;
Shvedova et al., 2005). To determine whether biodegradation
might render nanotubes non-inflammatory, in vivo tests on mice
were performed, showing that non-degraded nanotubes induced
the formation of tissue granulomas, whereas no granulomas
were observed in the lungs of mice exposed to biodegraded
SWNTs (Kagan et al., 2010). Moreover, carbon nanostructures
are susceptible of inducing formation of reactive oxygen species
(ROS). Yang et al. studied carbon nanohorns, a particular form
of carbon, also discovered by Iijima et al. (1999) and showed that
an excessive uptake by lysosomes induced lysosomal dysfunction
and consequent generation of ROS in the mitochondria (Yang
et al., 2014).
However, more recent studies have revealed that CNTs
can be made biocompatible through various dispersion and
functionalization strategies. Hence, Sayes et al. reported that
the toxicity of CNTs was dependent on the density of
surface functional groups, with minimal toxicity for heavily
decorated tubes (Sayes et al., 2006). Additionally, hydrophilic
groups introduced onto the CNTs surface render them more
biocompatible and biodegradable (Bianco et al., 2011). Besides,
structural defects on the SWNT surface allow oxidative enzymes
to degrade the buckytubes under environmentally relevant
settings (Allen et al., 2008). Simmons and co-workers exploited
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a non-covalent strategy to attach carboxylic functional groups
through pi–pi stacking interactions, thereby creating stable
aqueous dispersions and limiting cytotoxicity (Simmons et al.,
2009). RNA-wrapping is another attractive method to solubilize
CNTs without any toxic effect (Jeynes et al., 2006). Moreover,
Yang et al. showed that covalently PEGylated SWNTs exhibited
an ultralong blood circulation half-life in mice and no acute
toxicity has been reported even at a high dose (24mg kg−1)
(Yang et al., 2008). Recently, Maruyama and co-workers prepared
biocompatible MWNTs that were endocytosed mainly through
clathrins by human normal bronchial epithelial cells and
mesothelium cells, without any appararent toxicity (Maruyama
et al., 2015).
Hence, it appears that pristine CNTs and CNTs without
serum-stable functionalization show toxicity to cells at moderate
concentration, while serum-stable, functionalized CNTs show
minor toxicity even at high doses.
DEVELOPMENT OF BIOSENSORS OVER
TIME
The first biosensors appeared with the development of
electrochemical devices for detection of analytes in the 1950s.
The first and most famous of these is the electrochemical oxygen
biosensor described by Leland Clark Jr in 1956 (Clark oxygen
electrode), consisting of a platinum cathode at which oxygen is
reduced and a silver/silver chloride reference electrode (Clark,
1956). Clark and Lyons later combined this electrode with
glucose oxidase incorporated in a dialysis membrane to measure
the concentration of glucose in solution (Clark and Lyons, 1962).
A couple of years later the first “enzyme electrode” was described
by Updike and Hicks in 1967 to quantify glucose in solution
and in tissues in vitro, engineered through immobilization of
glucose oxidase in a polymerized gelatinous membrane that
coated a polarographic oxygen electrode (Updike and Hicks,
1967), thereby serving as an enzyme transducer to catalyze an
electrochemical reaction upon recognition of glucose (Clark and
Lyons, 1962).
In 1969 the first potentiometric enzyme electrode was
developed by Guilbault and Montalvo, the urea sensor, based
on immobilization of urease onto an ammonium-selective liquid
membrane electrode (Guilbault and Montalvo, 1969).
Ever since a broad range of biosensors have been developed
for in vitro and in vivo applications, whose nature varies from
enzymatic, to antibody, polypeptide, aptamer, or nucleic acids-
based. Likewise, the mechanism of transduction of biosensors
has evolved together with demand and technologies available,
from electrochemical and electronic biosensors to thermic
biosensors, that measure changes in temperature associated
with the amount of heat generated by an enzyme-catalyzed
reaction; microbial biosensors, that integrate micro-organisms
with a physical transducer, such as an electrochemical device,
to monitor specific analytes or biomarkers typically through
changes in respiration activity or production of electroactive
metabolites; immunobiosensors based on recognition of target
species by recombinant antibodies or antibody fragments;
optical biosensors, based on differences in optical diffraction,
changes in the emission of light signals upon recognition
of their target; and more recently nanobiosensors based on
nanomaterials which began to appear at the turn of the Twentieth
century (Turner et al., 1987; Morris, 2010; Turner, 2013;
Figure 5).
CARBON NANOTUBES FOR BIOSENSING
APPLICATIONS
With the explosion of nanotechnologies and the emergence of
nanomaterials with unique physicochemical properties, a new
class of biosensors referred to as nanobiosensors, which includes
nanoparticles and nanotubes, has been developed, that combines
the advantages of nanomaterials, notably their small size and
large surface/volume ratio, with the functionality of “macro”-
biosensors (Ferrari, 2005; Holzinger et al., 2014).
Nanomaterials offer attractive opportunities for biosensing
applications, to increase sensitivity and lower detection
limits. This enhanced performance is associated with the
small size of nanomaterials, which endows them with a
large surface/volume ratio. This high specific area enables
immobilization of greater concentrations of bioreceptor units
relative to biosensor surface/volume. Moreover, the inherent
physicochemical properties of many biomaterials enable them to
act as transducers.
CNTs offer several assets for detection purposes. By virtue
of their unprecedented structural, mechanical, electronic,
and optical properties CNTs offer several features of interest
to engineer new generation probes (Munzer et al., 2013;
Holzinger et al., 2014; Mundra et al., 2014). First, they constitute
scaffolds/platforms which may be functionalized through
conjugation of several entities, thereby potentially enhancing
recognition and signal transduction processes, as opposed to
mono-conjugated biosensor species, but also providing means
to multifunctionalize and therefore to multiplex. Through their
ability to conduct electricity (approximately 100 times greater
than copper wires), CNTs are well suited for transduction of
electric signals generated upon recognition of a target. Their
thermal conductivity is higher than diamond, and their strength
approximately 100 times greater than steel. Last but not least,
the ability of CNTs to cross biological membranes readily
makes them applicable in vivo with minimal invasiveness,
and they may further be employed for photoacoustic
imaging.
An ever-growing number of CNT-conjugates have been
developed for detection of DNA biomarkers, cell-surface
sugars, protein receptors and enzymes. Depending on their
mechanism of target recognition and transduction, these
biosensors are broadly subdivided into electronic transducers,
electrochemical CNT-biosensors, immunosensors, and optical
CNT-based biosensors (Figures 6–9).
Different classes of CNT biosensors have been developed to
probe a wide variety of cancer biomarkers through conjugation
or complexation of DNA or aptamers, antibodies, peptides,
proteins, or enzymes (Ferrari, 2005; Portney and Ozkan,
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FIGURE 5 | Biosensor development timeline.
2006; Choi et al., 2010). The incorporation of CNTs into
biosensing devices has enabled the development of highly
sensitive electrochemical biosensors for early-stage detection of
biomarkers of various diseases including cancer (Wang and
Dai, 2015). CNT-based immunosensors are still in the nascent
stage and there are many challenges to overcome for the
successful commercialization of the concepts (Veetil and Ye,
2007).More recent developments have led to application of CNT-
biosensors as imaging probes, in particular for photoacoustic
imaging.
Electrochemical and Electronic CNT
Biosensors
The larger part of biosensors developed to date are
electrochemical. They are popular due to their low-cost, relatively
fast response times, ease of use, and small size. Enzyme-coupled
electrochemical biosensors are based on enzymatic catalysis
of a reaction that produces electro-active species, thereby
generating a measurable electric signal. The biosensor generally
contains a reference electrode, a working electrode and a
counter electrode. The target analyte is recognized by enzymes
immobilized on the working electrode, catalytic activity of which
may cause either electron transfer, thereby producing a current
or contributing to produce a voltage (Figure 6A). Enzymes are
optimal biorecognition molecules, because they provide excellent
selectivity for their targeted substrate and have high catalytic
activity.
CNTs have been recognized very promising materials for
enhancing electron transfer, thanks to their electrical and
electrochemical properties, which make them suitable for
integration into electrochemical biosensors (Balasubramanian
and Burghard, 2006; Tothill, 2009; Bohunicky and Mousa, 2011;
Holzinger et al., 2014; Kumar et al., 2015; Wang and Dai,
2015). Their small size, large surface area, high conductivity,
high chemical stability and sensitivity (Zhao et al., 2002),
high electrocatalytic effect, and fast electron-transfer rate (Lin
et al., 2004) make them extremely well suited for biosensing
applications relying on enzymatic reactions and/or that generate
electro-active species. A wide variety of electrochemical CNT-
biosensors have been developed to detect ions, metabolites
and protein biomarkers (Wang and Dai, 2015). For instance,
several CNT-glucose biosensor based on conjugation of glucose
oxidase have been engineered (Lin et al., 2004; Patolsky et al.,
2004). Patolsky et al. reported on the structural alignment of
glucose oxidase (GOx) on electrodes using SWNTs as electrical
connectors between the enzyme redox centers and the electrode
(Figure 6B). They demonstrated that the surface-assembled
GOx was electrically contacted to the electrode by means
of the SWNTs, which acted as conductive nanoneedles that
electrically wire the enzyme redox-active site to the transducer
surface. Cholesterol biosensors consisting of modified screen
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FIGURE 6 | Electrochemical and Electronic CNT biosensors. (A) Typical design of an enzyme-based electrochemical biosensor. (B) SWNT electrically-contacted
glucose oxidase electrode. (C) Schematic illustration of a label-free amperometric biosensor for PSA detection. (D) Schematic illustration of a microfluidic chip based
on CNT electrodes (Yuichi et al., 2009).
FIGURE 7 | Electrochemical and Electronic CNT biosensors for Cancer Detection. (A) Schematic illustration of the folic acid-targeted cytosensing strategy for
an enhanced electrochemical detection of cancer cells using polydopamine-coated carbon nanotubes. (B) Schematic representation of an electrochemical DNA
biosensor for cancer detection based on gold nanoparticles/aligned CNTs.
printed electrodes with cholesterol esterase, peroxidase, oxidase
and MWNTs yield highly sensitive means of quantifying total
cholesterol in blood (Li et al., 2005).
Electrochemical biosensors based on functionalized CNTs
have further been developed for detection of nitric oxide (Santos
et al., 2013), epinephrine sensing (Prasad et al., 2013), and
dopaminemonitoring in rat striatum (Kress et al., 2014). An RNA
aptasensor for detection of disease-related glycoproteins in blood
was developed by coating SWNTs grafted with protein-specific
RNA aptamers on an alumina electrode (Zelada-Guillén et al.,
2013).
Zhang et al. reported the selective detection of cellular nitric
oxide (NO) by single-stranded d(AT)15 DNA oligonucleotide
adsorbed and wrapped around SWNTs (near-infrared fluorescent
single-walled carbon nanotubes) (Zhang et al., 2011). Jin et al.
developed SWNT-based biosensors of H2O2 which were applied
to single molecule imaging in human epidermal carcinoma cells
(Jin et al., 2010).
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Electronic monitoring of electrochemical biosensors
can be distinguished by the mechanism of transduction as
amperometric, potentiometric, conductometric, voltametric, or
piezoelectric systems.
Potentiometric biosensors measure the oxido-reduction
potential of an electrochemical reaction, and are therefore based
on biological reactions that produce or absorb hydrogen ions,
causing a net change in pH, which can be measured as an
electrical signal, potential, at the surface of a pH-meter probe.
Potentiometric biosensors make use of ion-selective electrodes
in order to transduce the biological reaction into an electric
signal.
Amperometric biosensors sense a current produced when a
potential is applied between two electrodes and can therefore
detect electro-active species present in biological samples, which
are most often produced thanks to enzymes.
Piezo-electric biosensors are based on piezo-electric
crystals (such as quartz) that vibrate under the influence of
an electric field. Their resonance frequency is proportional
to the mass of adsorbed material and therefore changes
as molecules adsorb or desorb from the surface of the
crystal.
In recent years, a large variety of amperometric biosensors
based on CNT-modified electrodes have been engineered. Fei
and co-workers carried out detection of cysteine on Pt/CNT
electrodes by cyclic voltammetry (Fei et al., 2005). Antiochia et al.
reported an amperometric CNT-biosensor developed by coating
CNT with a polymer of dihydroxybenzaldehyde (Antiochia
et al., 2004). Moreover, CNT-arrayed electrodes coated with anti-
PSA antibodies placed within a chamber were used to sense
PSA against a Pt wire counter electrode (Figure 6C; Okuno
et al., 2007). Biosensors based on CNTs arrayed on a chip, in
combination with pneumatic micropumps have been engineered
and applied to the simultaneous detection of several biomarkers
(PSA-mAb and human chorionic gonadotropin hCG antibodies)
(Figure 6D; Yuichi et al., 2009).
Electrochemical and Electronic CNT Biosensors for
Cancer Detection
Feng et al. reported a disposable paper-based bipolar electrode
(BPE) for the sensitive electrochemiluminescent detection of
prostate specific antigen (PSA) and showed that its response was
significantly improved after modification of the BPE cathode
with MWNTs (Feng et al., 2014). Besides, electrodeposition
of CNTs and their subsequent functionalization with proper
enzymes is used to ensure sensitivity and specificity in
electrochemical biosensing. Thus, MWNTs were used to
develop biosensors based on microsomal cytochrome P450 to
electrochemically detect drugs used in the treatment of breast
cancer (Baj-Rossi et al., 2012). Deposition of the CNT-enzyme
nanostructures onto the electrodes lowered the limit of drug
detection to fit the therapeutic range even in human serum.
Additionally, the same team synthesized a multi-array sensor
platform by electrodeposition of chitosan/MWNTs to detect
several endogenous metabolites (glucose, lactate) and drugs
(etoposide, mitoxantrone and etodolac) simultaneously, whilst
also monitoring pH and temperature for biosensing calibration
(Baj-Rossi et al., 2014).
A screen-printed carbon electrode used as the signal
transducer of a dsDNA-based biosensor was modified by
MWNTs and colloidal gold nanoparticles (GNPs) for testing
berberine, an isoquinoline plant alkaloid with significant
antimicrobial and anticancer activity (Ovádeková et al., 2006).
Detection of volatile organic compounds (VOCs) in human
breath to diagnose lung cancer is becoming an important
method for widespread screening, due to its facility and low cost
advantages. Thus, tricosane (C23H48)-functionalized SWNTs
biosensor showed pronounced sensitivity toward polar VOC
molecules, which can donate electrons to the nanotubes after
being absorbed (Liu et al., 2011).
D-(+)-galactose conjugated SWNTs were synthesized using
molybdenum electrodes for application as biosensors to detect
cancer marker galactin-3 (Park et al., 2011).
Later, Zheng and collaborators developed folic acid-
functionalized polydopamine-coated carbon nanotubes for
the electrochemical detection of HeLa and HL60 cancer
cells over-expressing the folate receptor (Zheng et al., 2012;
Figure 7A).
Fayazfar et al. reported on a new platform based on
electrochemical growth of gold nanoparticles on alignedMWNTs
for sensitive label-free DNA detection of the TP53 gene
mutation (Figure 7B; Fayazfar et al., 2014). The electrode
modified with vertically aligned MWNTs and gold nanoparticles
improved the density of the DNA probe as well as the sensor
sensitivity, displayed reproducibility and stability for 2 weeks,
and could be conveniently regenerated via dehybridization in
hot water. Alternatively, Au-Ag alloy-coated MWNTs were
used as sensing interface for ultrasensitive detection of volatile
biomarkers of MGC-803 gastric cancer cells (Zhang et al.,
2014b).
Recently, Shobba et al. evaluated the properties of both
SWNTs and MWNTs for early-stage detection of prostate cancer,
through functionalization with DNA strands that detect PSA
present in blood samples (Shobha and Muniraj, 2015).
CNTs have also emerged as promising sensing platforms for
amperometric detection and quantification of clinically relevant
metabolites such as glucose, cholesterol, lactate and glutamate,
and for detection of cancer biomarkers such as alpha-fetoprotein,
CEA, PSA, DNA, or microRNA biomarkers (Dey et al., 2013).
Several amperometric, impedimetric, and field-effect
transistors (FET) CNT-biosensors have been developed for
detection of cancer biomarkers and cells over the past couple of
years. For instance, a FET-CNT immunosensor was developed
for detection of osteopontin (OPN), a biomarker of prostate
cancer by attaching a genetically-engineered single chain
variable fragment protein with high binding affinity for OPN,
and employed to monitor this biomarker in a background
of concentrated bovine serum albumin (Lerner et al., 2012).
A vertically aligned carbon nanotube-based impedimetric
biosensor was fabricated through a photolithography process
on Ni/SiO2/Si layers for the detection of SW48 cells, isolated
from grade IV human colon tumors (Abdolahad et al., 2012,
2013).
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Bareket et al. prepared a rapid, sensitive, selective and
inexpensive CNT-modified screen-printed electrode to monitor
the amperometric response to formaldehyde released from
U251 human glioblastoma cells in response to treatment with
formaldehyde-releasing anticancer prodrugs (Bareket et al.,
2010).
More recently, a nanobiosensor was engineered for the
detection of liver cancer cells (HepG2) by using real time
electrical impedance sensing, through assembly of CNT
multilayers and antibodies to epithelial cell adhesion molecules
on an indium tin oxide electrode surface (Liu et al., 2014).
Detection of tumor cell antibodies caused increase of the
electron-transfer resistance and the electrochemical impedance
increased in a linear fashion with the logarithm of cancer cells
concentration.
CNT Immunosensors
Immunosensors rely on recognition of antigens by recombinant
antibodies or antibody fragments which can be immobilized onto
substrates and constitute the receptor moiety of the biosensor.
In 1983, Liedberg et al. developed the first immunosensor
through immobilization of antibodies onto a Chip, thereby
designing the precursor of the widely used BIAcore system,
which transduces immuno-recognition of analytes by surface
plasmon resonance (Liedberg et al., 1983). Ever since, a wide
variety of affinity reagents have become available for selective
recognition of biomarkers and target analytes, ranging from
recombinant antibodies and antibody fragments (scFvs and
Fabs) that can be selected from phage display libraries. To
date a large number of immunosensors have been engineered
to probe HIV, hepatitis and other viral diseases, to test
for drugs and monitor the presence of undesired or toxic
compounds in the environment. Although, the larger number
of these are electrochemical, both piezoelectric immunosensors
based on antibody-surface coated quartz crystals, and FET
immunosensors have been developed through conjugation of
antibodies to conductive nanomaterials (Veetil and Ye, 2007;
Kierny et al., 2012). Over the more recent years new generations
of nano-immunosensors have been engineered by immobilizing
recombinant antibodies or antibody fragments onto CNTs,
nanowires, nanoparticles, and quantum dots, thereby enhancing
binding capacity and sensitivity thresholds compared to more
traditional biosensors. Electrochemical immunosensors combine
a sensing interface for target detection with a sandwich-type
electrochemical immunoassay for amplification of the signal
(Figure 8A). Electrochemical immunosensors have also been
developed for cytosensing through functionalization of SWNTs
with RGDS peptides that recognize cell surface integrin receptors
(Figure 8B).
CNT Immunosensors for Cancer Detection
A wide variety of carbon-nanotube-based immunosensors have
been developed to probe cancer biomarkers (Veetil and Ye,
2007; Kierny et al., 2012). For instance, Rusling and co-
workers developed an electrochemical immunosensor based
on SWNT forests for the attachment of the enzymes or
antibodies by amidation (Rusling et al., 2009). Squamous cell
carcinomas of head and neck were detected thanks to an
ultrasensitive electrochemical immunosensor based on SWNT
forests incorporating antibodies to Interleukin-6 (Il-6) and
horseradish peroxidase enabling detection of very low and
elevated levels of Il-6 (Malhotra et al., 2010). A multiplexing
electrochemical immunosensor based on screen-printed carbon
electrodes was developed for simultaneous detection of PSA
and Interleukin-8 (Il-8) (Wan et al., 2011). Recently, an
impedimetric immunosensor of human epidermal growth factor
receptor 2 (HER2) was developed by modification of a gold
nanoparticle-decorated MWNT-ionic liquid electrode (Arkan
et al., 2015). Gold nanoparticles were used to enhance the
extent of immobilization and to retain the immunoactivity of
the HER2 antibody Herceptin on the electrode. This biosensor
enabled detection of low concentrations of HER2 in serum
samples of breast cancer patients and exhibited a linear
increase in charge transfer resistance with the concentration
of HER2.
Optical CNT Biosensors
By definition, optical biosensors report on detection of target
biomolecules or analytes through changes in the emission of light
(UV, visible, or infrared) (Figure 9A).
Following the first fiber optic biosensor or “optode” described
by Lubbers and Oppitz to measure carbon dioxide, oxygen and
alcohol, respectively (Lubbers and Opitz, 1975; Völkl et al.,
1980), a wide variety of optical biosensors have been developed
to study and report on dynamic biomolecular processes
in vitro, in living cells and in vivo (Cooper, 2002; Martins
et al., 2013). Optical biosensors can be distinguished according
to the method used to readout target detection (surface
plasmon resonance, absorbance, reflectance, fluorescence,
phosphorescence, luminescence, wavelength intensity, lifetime,
anisotropy, quenching, and fluorescence energy transfer) or
by their mechanism of recognition (probing biosensors and
reacting biosensors). Probing biosensors monitor differences in
the interaction/affinity between analyte and recognition domain
of the sensor which lead to changes in optical response. Reacting
biosensors exhibit different optical responses related to chemical
processes (chemisorption, catalytic reaction, formation of new
chemical bonds, etc.). Over the past decade, a number of optical
biosensors based on surface plasmon resonance, waveguides,
and resonant mirrors have been developed to monitor label-
free targets in vitro (Cooper, 2002). Colorimetric biosensors
measure changes in light absorption as reactants are converted to
products. Photometric light intensity biosensors detect changes
in fluorescent or bioluminescent processes associated with
changes in the spectral properties of probes involved directly or
indirectly in target detection.
Fluorescence offers particularly attractive advantages for
biosensing applications, such as its high inherent sensitivity
and the opportunity to image dynamic processes in living cells
by fluorescence microscopy in a non-invasive fashion with
high spatial and temporal resolution (Zhong, 2009). Target
recognition is transduced through emission of a fluorescent
signal which differs from that of the biosensor in its unbound
state. Fluorescent biosensors have been designed to recognize and
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FIGURE 8 | Immuno-CNT biosensors. (A) Schematic representation of an electrochemical CNT-immunosensor that combines a sensing interface for target
detection with a sandwich-type electrochemical immunoassay for amplification of the signal. (B) Cytosensing immunosensor based on functionalization of SWNTs
with RGDS peptides that recognize cell surface integrin receptors.
FIGURE 9 | Optical CNT biosensors. (A) Schematic representation of a genetically-encoded FRET kinase biosensor: the donor (GFP) and acceptor (RFP) proteins
are brought in close proximity which enables FRET following a phosphorylation-mediated intramolecular conformational change. (B) Schematic representation of
non-genetic, environmentally-sensitive peptide-based biosensor: the probe environment is altered upon phosphorylation of the substrate. (C) CNT-biosensor based
on wavelength shift of fluorescence upon target binding to a receptor conjugated into the SWNT. (D) Optical biosensor of ssDNA: fluorescence of a dye-labeled
oligonucleotide is quenched upon non-covalent assembly with SWNT, until the ssDNA target binds and releases the labeled oligonucleotide from the SWNT. (E)
Photoacoustic detection of integrins by indocyanine-labeled SWNT-biosensor conjugated with RGD peptides (Zerda et al., 2010).
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report on the presence, activity or conformation of a given target
in a specific and quantitative fashion, thereby providing means to
probe its dynamic molecular behavior through sensitive changes
in fluorescence.
The first fluorescent biosensors were developed in the 1990s
(de Silva et al., 1997; Johnson, 1998; Terai and Nagano,
2008). Although they were initially based on incorporation
of synthetic probes that are sensitive to changes in their
environment into biosensor receptor moieties, the discovery of
the Green Fluorescent Protein (GFP) and its engineering into
genetically-encoded reporters paved the way for development
of genetically-encoded fluorescent biosensors (Tsien, 1998, 2005;
Ellenberg et al., 1999; Bastiaens and Pepperkok, 2000; Lippincott-
Schwartz et al., 2001; Wouters et al., 2001; Zhang et al.,
2002; Lippincott-Schwartz and Patterson, 2003; Shaner et al.,
2005, 2007; Giepmans et al., 2006; Fernandez-Suarez and Ting,
2008). This class of biosensors relies on ectopic expression
of genetically-encoded autofluorescent protein (AFP) fusions
with receptor domains that recognize the target of interest in
living cells. For the larger part these are single-chain biosensors
which respond to enzymatic activities through fluorescence
resonance energy transfer (FRET) (Ibraheem and Campbell,
2010; Morris, 2010; Van and Morris, 2013). For instance
genetically-encoded FRET biosensors of protein kinases, also
known as KARs (kinase activity reporters) incorporate a pair
of genetically-encoded AFPs together with an enzyme-specific
substrate sequence and a phosphoaminoacid binding domain
(PAABD). When the substrate sequence is phosphorylated by
the kinase of interest, it preferentially interacts with the PAABD,
thereby inducing an intramolecular change which brings the
AFPs closer and promotes fluorescence energy transfer between
the donor and the acceptor (Tsien, 1998; Zhang et al., 2002;
VanEngelenburg and Palmer, 2008; Aye-Han et al., 2009; Wang
et al., 2009; Ibraheem and Campbell, 2010; Morris, 2010;
Figure 9A).
More recent efforts made by chemists have yielded a palette
of environmentally-sensitive synthetic fluorophores that respond
to changes in the polarity of their environment, becoming more
fluorescent in non-polar solvents or upon interaction with a
hydrophobic target protein with enhanced spectral properties
for in vivo imaging which can be conjugated to peptide/protein
scaffolds, yielding attractive alternatives to their genetically-
encoded counterparts (Tsien, 1998, 2005; Ellenberg et al., 1999;
Bastiaens and Pepperkok, 2000; Lippincott-Schwartz et al., 2001;
Wouters et al., 2001; Zhang et al., 2002; Lippincott-Schwartz
and Patterson, 2003; Shaner et al., 2005, 2007; Giepmans et al.,
2006; Fernandez-Suarez and Ting, 2008; Lavis and Raines,
2008; Loving et al., 2009). These systems are more readily
applicable in vitro and can further bemicroinjected or introduced
into living cells through facilitated delivery. They have proven
sensitive and particularly well suited to monitor protein kinase
activities (Pazos et al., 2009; Wang et al., 2009; Morris,
2010; González-Vera, 2012; Nhu Ngoc Van and Morris, 2013;
Figure 9B).
Fluorescent biosensors have been widely used by cell biologists
to study the spatio-temporal dynamics and activities of enzymes
in living cells and in real-time in physiological and pathological
contexts, providing information which could not be obtained
through traditional biochemical approaches. But these tools
have also been largely implemented to biomedical applications,
to highlight alterations in pathological disorders, and in drug
discovery programmes to screen for, validate and characterize the
efficacy of newly identified candidate drugs (Morris, 2012; Prével
et al., 2014).
Likewise, CNTs constitute attractive biosensing devices
for biomarker detection and imaging. SWNTs are indeed
characterized by inherent photoluminescence between 650
and 1400 nm, which allows for deep penetration and imaging
in biological tissues and organs with near- and infrared light
(Smith et al., 2009). Unfunctionalized SWNTs possess low
fluorescence stability, intensity, and biocompatibility. In
contrast, surface functionalization, environmental changes, or
interactions with target biomolecules affect SWNT fluorescence
emission signals significantly (wavelength and intensity)
(Chen et al., 1998; Moore et al., 2003), thereby making
them well suited for fluorescence-based sensing applications
(Boghossian et al., 2011; Iverson et al., 2013). Moreover, although
SWNTs respond to changes in local dielectric function, they
remain stable to photobleaching, therefore offering attractive
opportunities for biomedical imaging applications (Barone et al.,
2005).
For instance, SWNTs have been coupled to beta-D-glucose
(Barone et al., 2005). SWNT/luciferase conjugates have been
implemented for NIR detection of ATP in living cells (Kim
et al., 2010). A chaperone sensor for nitrosoaromatics was
engineered thanks to peptides immobilized on the CNT surface
and further applied to image changes in peptide conformation
associated with recognition of the molecular target through NIR
photoluminesence (Heller et al., 2011; Figure 9C). Stabilization
of SWNTs with genetically engineered M13 phage has been
used for in vivo fluorescence imaging in deep tissues following
intravenous injection (Yi et al., 2012). Likewise, non-covalent
assembly of SWNTs with dye-labeled oligonucleotide yielded an
optical biosensor of single-stranded DNA (ssDNA), fluorescence
of which is quenched until the ssDNA target binds and releases
the labeled oligonucleotide from the SWNTs (Yang et al., 2008;
Figure 9D). Heteropolymers of SWNTs coated with a corona
phase designed to recognize different metabolites (riboflavin,
L-thyroxine and oestradiol) were used for NIR imaging of
these compounds in space and in time in murine macrophages
(Zhang et al., 2013). More recently, a label-free sensor of
the troponin T was fabricated by immobilizing onto chitosan-
wrapped nanotubes and used to detect this cardiac biomarker of
acute myocardial infarction by NIR fluorescence (Zhang et al.,
2014a).
Optical CNT Biosensors for Cancer Detection
SWNTs-Indocyanine Green (ICG) conjugated with cyclic Arg-
Gly-Asp (RGD) peptides to target alpha(v)beta(3) integrins
were shown to serve as sensitive photoacoustic contrast agents
following intravenous administration in to tumor-bearing mice,
achieving subnanomolar sensitivity and 300 times higher
photoacoustic contrast in living tissues than previously reported
SWNTs (Zerda et al., 2010; Figure 9E).
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SWNTs have been used to incorporate a fluorescent cyclin
A binding motif derived from p21WAF1. A simple, selective
and ultrasensitive fluorescence assay was developed for detection
of cyclin A, a cell cycle regulator which is overexpressed
in certain human cancers. The fluorescence of cyclin A
binding peptide was quenched by energy transfer and electron-
transfer processes but displayed fluorescence enhancement upon
recognition and binding of cyclin A. This strategy demonstrated
a nanomolar limit of detection of cyclin A and was thus
proposed as a prognostic indicator of early stage cancer
(Wang et al., 2010).
CONCLUDING REMARKS — CHALLENGES
AND OUTLOOK
With the growing demands of our society, in particular
healthcare issues associated with aging of the population,
next generation medical diagnostics require implementation
of rapid, sensitive and cost-effective alternatives to the more
traditional immunological assays currently used. Similarly, the
detection of pathogens and toxic compounds in our environment
constitute major threats and sensitive detection procedures are
required to address concerns for our agriculture and global
security.
An evergrowing number of biosensing devices and strategies
have been developed since the Clark oxygen electrode in
the 1950s. However, nanomaterials have clearly provided new
and attractive platforms to engineer biosensors with enhanced
sensitivity and performance. In particular, the structural,
electronic, and optical properties combined by CNTs offer
a wealth of opportunities to develop new generation nano-
tools for biosensing applications, especially for probing disease
markers.
The electronic properties of CNTs are extremely well suited
for electrochemical, amperometric, impedometric, or field-effect
transduction of signals, but their particular optical properties and
their ability to penetrate readily through biological membranes
also make them suitable candidates for the development of
photoacoustic imaging sensors.
However, when proposing a biosensor, it is always
recommended to take into consideration that nanoscale
materials, although small, are not insignificant to leaving bodies;
they can be sensed as intruders and consequently attacked.
Therefore, issues related to their length, diameter, lifetime,
stability, durability, mechanical properties, body adjustment,
and toxicity must be evaluated by a scientific and systematic
method. Indeed, when used in their pristine state, directly after
synthesis, CNTs contain impurities and can have harmful effects.
Nonetheless, when purified and surface-functionalized, their
toxicity is drastically decreased and they represent optimal
platforms for all kinds of applications. Besides, it was shown that
continuous CNT fibers open a safe way to avoid the potential risk
of CNT leaching, especially when used in implantable electrodes
for in vivo testing (Zhu et al., 2010).
The high specific area of CNTs is a major advantage
for biosensing applications, allowing for conjugation or
complexation of an important number of receptor moieties,
thereby contributing to increased recognition of targets or
analytes, and consequently lowering the detection sensitivity
threshold. CNTs have comparable dimensions to redox proteins
and can be used as effective electrical wiring/connectors with
redox enzymes. However, better control of the chemical and
physical properties of the CNT biosensors is still needed. For
example, the separation process for different types of CNTs,
the miniaturization of the sensors and the in vivo stability
need to be addressed to meet feature requirements. Besides,
the nanowire morphology of CNTs enables the approach
to the active centers of redox enzyme leading to fast and
efficient electron transfers. In addition, cost-effective, large scale
fabrication of CNT nanoelectrode arrays is an attractive option
to produce greater currents than single nanoelectrodes, thereby
circumventing requirement for expensive electronic devices,
whilst improving the signal to noise ratio (Li et al., 2003). Hence,
CNTs can overcome most disadvantages of a conventional
electrochemical biosensor (including poor sensitivity and
stability, low reproducibility, and large response times for
electron transfer reactions) owing to their ability to undergo fast
electron transfer and the resistance of CNT-modified electrodes
to surface fouling, yielding ultrasensitive electrochemical sensors.
Importantly, the multifunctionalization of CNTs allows
the design of biosensors for multiplexed detection of several
biomarkers simultaneously. Although this constitutes a
challenging objective, surface treatments, coating, and selective
incorporation of chemical groups enable the functionalization of
multiple biosensing moieties. Moreover, since functionalization
has been shown to reduce the toxicity of CNTs, making them
more biocompatible, and thereby addressing one of the major
issues of these otherwise potent nanomaterials for cellular and
in vivo applications, it clearly kills two birds with one stone.
CNTs therefore constitute versatile and multifunctional
nanostructures which combine the potential to serve for
diagnostic and therapeutic applications. Whilst they may
serve as biosensors of cancer biomarkers with demonstrated
characteristics of high sensitivity, reliability, and inexpensive
microfabrication for cost effectiveness, they can also be loaded
with anticancer drugs and used as therapeutic platforms in
oncology. They may also be used for photothermic ablation of
tumors and for photoacoustic molecular imaging of cancer cells.
So, could CNTs be the Prince Charming the biosensor field was
expecting?
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